Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Gordon Srkalovic M.D."'
Autor:
Ruben Niesvizky, David T. Siegel, Bart Barlogie, David Irwin, S. Vincent Rajkumar, Steven Limentani, Sundar Jagannath, Gordon Srkalovic M.D., Elizabeth Trehu, Raymond Alexanian, Dixie L. Esseltine, James R. Berenson, Melissa Alsina, Kenneth Anderson, Seema Singhal, David P. Schenkein, Paul G. Richardson
Publikováno v:
Cancer. 104(10)
Background Bortezomib, a first-in-class proteasome inhibitor, is active with manageable toxicities in relapsed and/or refractory myeloma. Methods Bortezomib 1.0 or 1.3 mg/m2 was administered Days 1, 4, 8, and 11 every 21 days for up to 8 cycles to pa